Aliri Bioanalysis

?? Meet Jeremy Rochford,?Senior Director, Business Development! Jeremy recently joined the Aliri team, bringing 18+ years of experience working in the CRO space, most recently holding positions at KCAS, Eurofins, and Pace Analytical. Based in the suburbs of Boston, he is looking forward to supporting sponsors in the Northeast, sharing, “I’m excited for the opportunity to partner with groundbreaking sponsors that are working incredibly hard to impact the lives of patients battling tough diseases.” Reach out to schedule a meeting with Jeremy and explore Aliri's bioanalytical and spatial biomarker solutions. ? https://lnkd.in/e2EPiyhJ?

The Aliri leadership team was honored to be joined by?industry colleagues and friends for an intimate dinner overlooking the stunning Barcelona coastline and Mediterranean Sea, after a productive day at the EBF Open Symposium. We are incredibly grateful to be a trusted partner to so many innovative organizations and are excited at the endless possibility that the future holds. Cheers to scientific excellence and collaboration!?

What an energizing few days it has been at the #EBF Open Symposium in Barcelona, Spain! Thank you to all who joined our colleague, David Bonnel, PhD at his featured presentation on how to identify predictive #biomarkers for immuno-oncology therapy. We know this proprietary data science workflow has immense potential to enable breakthroughs in?personalized medicine. There is still time to visit Aliri’s scientific posters tomorrow and consult our #ATeam on challenges you may be experiencing in your drug development program. ? Reach out to schedule a meeting here: https://lnkd.in/ge9ATzRw?

Is a drug-drug interaction (#DDI) risk a concern for your chemical entity? Find out quickly with Aliri’s fully validated, non-proprietary #assay for measuring 4β=hydroxycholesterol using the latest mass spectrometry technology. This derivitization-free method requires a smaller sample volume while ensuring high-quality data that is FDA compliant. Click here to download the scientific poster, which was presented by Shane Karnik at AAPS PharmSci 360:?https://lnkd.in/eFB_u5-u?

Meet Aliri expert, Mathieu Gaudin, PhD, Director of Laboratory Operations for our Lille, France location. Mathieu has over 17 years of experience in mass spectrometry-based bioanalysis and is passionate about how drug metabolism and pharmacokinetics (DMPK) can influence the clinical future of many preclinical drug candidates. Visit our website to learn more about how Mathieu and the rest of the Aliri A Team can expedite your next development project! https://lnkd.in/eatq9XYC

Aliri’s?People First value is embedded in everything we do, to ensure that our employees have the right tools to succeed, and that we are delivering on our promises to customers, as they work to bring life-saving treatments to patients around the world. ?? ? Below, our colleague Shawn Burton, Principal Analytical Investigator, shares a personal connection he has to our?#PeopleFirst value, which motivates him every day at Aliri. ? ? Learn more about our guiding principles: https://lnkd.in/egehSn8B

Today, on #WorldDiabetesDay, we feel energized by the rapid innovation that has taken place in recent years to treat those who are living with this serious health condition. Aliri is proudly positioned to support the bioanalysis of all diabetes treatments, and we are specifically excited about the science around #SGLT2 inhibitors, a new investigational approach?for treating diabetic kidney disease (#DKD) through enhancing renal pathophysiology. Leverage our team’s 30 years of expertise?to get fast access to meaningful data, so you can get your treatment in the hands of patients who need it. Learn more at https://lnkd.in/ewW3ygMj #PeopleFirst #CRO #Bioanalysis

Meet us in San Francisco! Aliri is looking forward to a day of enriching discussions at the upcoming #PBSS bioanalytical workshop in Foster City, CA on November 14! Will you be attending with the goal of solving bioanalytical challenges within your development program? Connect with our colleague, Richard Egolf, to learn how Aliri can deliver quality data with speed and agility. Reach out to schedule a meeting! https://lnkd.in/euu3mYmE?

Aliri is proud to be sharing?an exciting lineup of highly relevant scientific presentations at the upcoming European Bioanalysis Forum Open Symposium, in Barcelona, Spain, this 20-22 November. Which of our #EBF presentations will you be stopping by? ?? Featured Talk by David Bonnel, PhD:?Integrating #MassSpectrometry Imaging and #SpatialTranscriptomics for Clinical Insights into Disease Complexity and Drug Response | 22 November from 14:40 – 15:00. ??Poster:?Quantifying and mapping #ATP distribution within tissues to inform targeted therapeutic strategies in drug development ??Poster:?Exploring the Spatial Distribution of #mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using #MALDI MSI ??Poster:?Maximizing Reproducibility and Sensitivity in #qPCR for Detecting Transcripts Over a Broad Dynamic Range in Response to Anti-PD-1 Therapy ??Poster:?Distribution of standard-of-care antituberculosis drugs in cynomolgus macaque lungs Request?a?meeting with our team at EBF! https://lnkd.in/e_ZxyS5S

Last chance to register for?tomorrow's free webinar! ?? Don't miss out on this?information-packed session exploring real, data-backed applications for #AI in the drug development process, with a specific focus on how this powerful tool in conjunction with genomic, proteomic, and metabolomic analyses can help predict the effectiveness of #immunotherapies earlier than traditional methods allow. Tune in to hear expert perspectives on: ?? The state of AI in the pharmaceutical landscape ??Applications for AI in drug development and bioanalysis ??How to combine AI and spatial omics for precision medicine REGISTER NOW: https://lnkd.in/eWMdqEUU